Immune effector process
- ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
- ACTB: actin, beta
- ACTG1: actin, gamma 1
- APOA1: apolipoprotein A-I
- ATP7A: ATPase, Cu++ transporting, alpha polypeptide
- BTK: Bruton agammaglobulinemia tyrosine kinase
- C3: complement component 3
- CD40LG: CD40 ligand
- CFH: complement factor H
- CFHR5: complement factor H-related 5
- CFI: complement factor I
- CLCF1: cardiotrophin-like cytokine factor 1
- FOXP3: forkhead box P3
- HLA-DQB1: major histocompatibility complex, class II, DQ beta 1
- HLA-DRB1: major histocompatibility complex, class II, DR beta 1
- IL23R: interleukin 23 receptor
- INS: insulin
- KIT: v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
- KRT1: keratin 1
- LIMK1: LIM domain kinase 1
- LYST: lysosomal trafficking regulator
- MBL2: mannose-binding lectin (protein C) 2, soluble
- MSH2: mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
- MSH6: mutS homolog 6 (E. coli)
- PLA2G6: phospholipase A2, group VI (cytosolic, calcium-independent)
- PML: promyelocytic leukemia
- PRF1: perforin 1 (pore forming protein)
- PROS1: protein S (alpha)
- RARA: retinoic acid receptor, alpha
- RPS19: ribosomal protein S19
- SAMHD1: SAM domain and HD domain 1
- SERPING1: serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
- TGFB1: transforming growth factor, beta 1
- UNC13D: unc-13 homolog D (C. elegans)
- WAS: Wiskott-Aldrich syndrome
Source: Gene Ontology Consortium
.
